Hyperlipidemia: Difference between revisions
Jump to navigation
Jump to search
Line 42: | Line 42: | ||
==Treatment== | ==Treatment== | ||
===Trial supportive data=== | ===Trial supportive data=== | ||
====[[Niacin]]==== | ====[[Niacin]]==== |
Revision as of 14:51, 24 August 2012
For patient information click here Template:DiseaseDisorder infobox
Lipoprotein Disorders Microchapters |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Hyperlipidemia from other Diseases
Epidemiology and Demographics
Risk factors
Screening
Screening tests | Screening frequency
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Staging | Laboratory Findings | Electrocardiogram | Chest X Ray | CT | MRI | Echocardiography | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention
Case Studies
Treatment
Trial supportive data
Niacin
AIM HIGH study
References
External links
Hyperlipoproteinemia | OMIM | GPnotebook | WebMD | Others |
---|---|---|---|---|
Type I | Online Mendelian Inheritance in Man (OMIM) 238600 | Template:GPnotebook | . | MeritCare |
Type IIa | Online Mendelian Inheritance in Man (OMIM) 144400 | Template:GPnotebook | . | Merck |
Type IIb | Template:GPnotebook | . | ||
Type III | . | Template:GPnotebook | WebMD | Yahoo |
Type IV | Online Mendelian Inheritance in Man (OMIM) 144600 | Template:GPnotebook | WebMD | Yahoo |
Type V | Online Mendelian Inheritance in Man (OMIM) 144600 | Template:GPnotebook | . | . |